N. Cedar

Molecular epidemiology and mapping of tuberculosis in Israel: do migrants transmit the disease to locals?

Z. Mor, E. Rorman, Z. Dveyrin, 2014, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Myocarditis after BNT162b2 mRNA Vaccine against Covid-19 in Israel

Manfred S. Green, D. Mevorach, E. Anis, 2021, The New England journal of medicine.

Drug-resistant tuberculosis in Israel: risk factors and treatment outcomes.

Z. Mor, E. Rorman, D. Chemtob, 2014, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Myocarditis after BNT162b2 Vaccination in Israeli Adolescents

Manfred S. Green, D. Mevorach, E. Anis, 2022, The New England journal of medicine.

Myocarditis After BNT162b2 COVID-19 Third Booster Vaccine in Israel

Manfred S. Green, D. Mevorach, E. Anis, 2022, Circulation.

Childhood tuberculosis in Israel: epidemiological trends and treatment outcomes, 1999–2010

H. Bibi, I. Grotto, Z. Mor, 2012, European Respiratory Journal.

Adult tuberculosis in Israel and migration: trends and challenges between 1999 and 2010.

I. Grotto, Z. Mor, M. Lidji, 2012, The International Journal of Tuberculosis and Lung Disease.

Tuberculosis Incidence in HIV/AIDS Patients in Israel, 1983–2010

I. Grotto, Z. Mor, M. Lidji, 2013, PloS one.

Erratum to: ‘HIV prevalence in the Israeli tuberculosis cohort, 1999–2011’

I. Grotto, Z. Mor, M. Lidji, 2016, BMC Public Health.

Reporting of Allergic Reactions During Pfizer-BioNTech BNTT162B2 Vaccination in Israel

E. Anis, A. Hershko, Y. Tal, 2022, The Journal of Allergy and Clinical Immunology: In Practice.